ALK and anaplastic large cell lymphoma: Of note, in ALK+ ALCL, while the occurrence of apoptosis following diverse therapies has been widely reported, the occurrence of necroptosis was only described in CD30 antibody-treated cells in combination with NFκB/proteasome inhibitors [84].